Russell Investments Group
PAHC icon

Russell Investments Group’s Phibro Animal Health PAHC Stock Holding History

Russell Investments Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.76M Sell
183,563
-9,873
-5% -$417K 0.01% 1424
2026
Q1 		$10.7M Buy
193,436
+13,909
+8% +$662K 0.01% 899
2025
Q4 		$6.71M Sell
179,527
-367
-0.2% -$14.9K 0.01% 1138
2025
Q3 		$7.27M Sell
179,894
-28,179
-14% -$931K 0.01% 1082
2025
Q2 		$5.31M Buy
208,073
+85,473
+70% +$1.86M 0.01% 1181
2025
Q1 		$2.62M Buy
122,600
+107,485
+711% +$2.4M ﹤0.01% 1542
2024
Q4 		$317K Buy
15,115
+7,011
+87% +$162K ﹤0.01% 2407
2024
Q3 		$183K Buy
8,104
+8,080
+33,667% +$156K ﹤0.01% 2536
2024
Q2 		$402 Hold
24
– – ﹤0.01% 3515
2024
Q1 		$310 Buy
+24
New +$288 ﹤0.01% 3254
2023
Q3 		– Sell
-68
Closed -$932 – 3600
2023
Q2 		$932 Buy
68
+36
+113% +$516 ﹤0.01% 3329
2023
Q1 		$490 Sell
32
-30,775
-100% -$470K ﹤0.01% 3128
2022
Q4 		$413K Sell
30,807
-85,066
-73% -$1.14M ﹤0.01% 2344
2022
Q3 		$1.54M Sell
115,873
-61,784
-35% -$1.07M ﹤0.01% 1703
2022
Q2 		$3.4M Buy
177,657
+29,796
+20% +$564K 0.01% 1300
2022
Q1 		$2.95M Buy
147,861
+39,456
+36% +$797K 0.01% 1430
2021
Q4 		$2.21M Buy
108,405
+34,385
+46% +$734K ﹤0.01% 1746
2021
Q3 		$1.59M Sell
74,020
-35,174
-32% -$847K ﹤0.01% 1953
2021
Q2 		$3.15M Buy
109,194
+31,415
+40% +$850K 0.01% 1642
2021
Q1 		$1.9M Sell
77,779
-2,829
-4% -$63.9K ﹤0.01% 1908
2020
Q4 		$1.56M Sell
80,608
-25,831
-24% -$475K ﹤0.01% 1890
2020
Q3 		$1.85M Buy
106,439
+39,688
+59% +$847K ﹤0.01% 1736
2020
Q2 		$1.74M Buy
66,751
+8,392
+14% +$208K ﹤0.01% 1725
2020
Q1 		$1.38M Buy
58,359
+5,794
+11% +$142K ﹤0.01% 1669
2019
Q4 		$1.3M Sell
52,565
-6,835
-12% -$159K ﹤0.01% 1970
2019
Q3 		$1.26M Buy
59,400
+18,721
+46% +$513K ﹤0.01% 1894
2019
Q2 		$1.29M Buy
40,679
+19,468
+92% +$610K ﹤0.01% 1877
2019
Q1 		$689K Sell
21,211
-4,051
-16% -$126K ﹤0.01% 2225
2018
Q4 		$803K Buy
25,262
+293
+1% +$11.1K ﹤0.01% 2090
2018
Q3 		$1.06M Buy
24,969
+1,000
+4% +$47.2K ﹤0.01% 2088
2018
Q2 		$1.1M Sell
23,969
-9,671
-29% -$428K ﹤0.01% 2079
2018
Q1 		$1.33M Sell
33,640
-2,919
-8% -$108K ﹤0.01% 2065
2017
Q4 		$1.23M Sell
36,559
-7,614
-17% -$270K ﹤0.01% 2045
2017
Q3 		$1.64M Buy
44,173
+3,105
+8% +$117K ﹤0.01% 1894
2017
Q2 		$1.52M Buy
41,068
+14,420
+54% +$471K ﹤0.01% 1897
2017
Q1 		$748K Buy
+26,648
New +$752K ﹤0.01% 2256

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Russell Investments Group's PAHC Position: Q2 2026 in Review

Russell Investments Group reduced its Phibro Animal Health (PAHC) stake by 5.1% in Q2 2026, selling an estimated $417K and leaving 183,563 shares worth $5.76M. The position accounts for 0.01% of the portfolio, ranked #1424.

Russell Investments Group first reported a position in PAHC in Q1 2017 and has held it in 36 quarters since. The position peaked at $10.7M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Russell Investments Group held 183,563 shares of Phibro Animal Health worth $5.76M as of Q2 2026.
  • Russell Investments Group sold 9,873 Phibro Animal Health shares in Q2 2026, an estimated $417K.
  • Phibro Animal Health made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1424 holding.
  • Russell Investments Group first reported a position in Phibro Animal Health in Q1 2017 and has held it in 36 quarters since.
  • Russell Investments Group's Phibro Animal Health position peaked at $10.7M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.